Company: BLUWU
Filing Date: 2025-05-23
Form Type: S-1/A
Source: 0001641172-25-012302
Chunk: 154

Company: Blue Water Acquisition Corp. III
Filing Date: 2025-05-23
Form: S-1/A
Chunk 154
---
 are revolutionizing industries through advanced technological solutions. Key areas of interest include:

| ● | Artificial Intelligence                                                                                                       
 and Machine Learning: We intend to invest in AI-driven companies that offer transformative solutions across multiple sectors. |

| ● | Cloud Computing: Our                                                                             
 focus includes businesses that provide scalable and efficient cloud infrastructure and services. |

| ● | Cybersecurity: We                                                                                                
 prioritize investments in companies developing cutting-edge cybersecurity solutions to enhance digital security. |

| ● | Enterprise Software Solutions:                                                                                
 Our strategy supports software companies that enhance business efficiency, productivity, and decision-making. |

| 106 |

<div align='center'>Our Founders and Management Team</div>

Our management team comprises seasoned professionals with extensive experience across the biotechnology, healthcare, and technology sectors. With backgrounds in leadership positions at top 500 public companies, our team possesses a deep understanding of industry dynamics and investment strategies essential for driving success.

Our management team has accumulated decades of experience with top public companies, achieving significant milestones, such as:

| ● | Leading R&D initiatives                                                        
 in major pharmaceutical firms, culminating in the launch of blockbuster drugs. |

| ● | Developing and scaling health                     
 technology startups acquired by industry leaders. |

| ● | Managing large-scale IT projects                                       
 within multinational corporations to enhance operational efficiencies. |

| ● | Spearheading strategic initiatives                                                    
 in biotechnology firms that resulted in groundbreaking discoveries and FDA approvals. |

| ● | Successfully spinning out                                                                              
 over 12 companies and bringing five public through reverse mergers, direct IPOs, and M&A transactions. |

Joseph Hernandez, our Chairman and Chief Executive Officer since inception, is an entrepreneurial leader with over 25 years of experience in the healthcare field. He is the Founder of Blue Water Venture Partners, LLC, an investment firm, where he is also the Senior Managing Partner. Along with Blue Water Venture Partners, LLC, Mr. Hernandez is the Chairman and Founder of several other biotechnology companies including, Perseus Therapeutics, Inc., spun out of Duke University and focused on developing novel therapies for preventing hair loss in chemotherapy-treated cancer patients and for cosmetic use; Temple Street Biotech, Inc., focused on advancing Alzheimer’s disease treatments; Eternity Biotech, spun out of Yale University and committed to developing advancements life extension; and Energia Power Systems, Inc., spun out of Stanford University, a novel battery company. Mr. Hernandez has a background in company creation, early stage technology development, as well as private and public market financing. Mr. Hernandez brings leadership to the